BGI will join the Precision Medicine Expo & Summit (PMES) in Dubai on May 24-25. The event gathers healthcare providers, academic researchers, and industry experts to share information about precision medicine, and BGI will showcase its integrated solutions of reproductive health and oncology.
The vice president of BGI international project center, Mr. Renyuan Luo, will attend the summit as a speaker. He will introduce his experience in non-invasive prenatal testing (NIPT) and carrier screening and the genetic screening of oncology and infectious diseases, discussing the topic of “Making Precision Medicine Accessible to Everyone”.
BGI has promoted the application of gene sequencing technology around the world, contributed to the efforts of fighting against the COVID-19 pandemic, and delivered independent strong scientific research and technological support to the global health community.
We are looking forward to presenting at this global summit, and we sincerely invite everyone to visit us in the A01 booth area.
BGI Genomics is the world’s leading provider of genomic sequencing services and proteomic services, now serving customers in more than 66 countries. We provide academic institutions, pharmaceutical companies, health care providers and other organizations with integrated genomic sequencing, proteomic services and solutions across a broad range of applications.
Globally, BGI accelerates scientific and technological innovation, actively develops industrial layout, exports "Chinese technology" to the world's public health system, and also provides solid strength during the fight against COVID-19 epidemic. Up to now, BGI's COVID-19 detection products have covered more than 180 countries and regions, and more than 90 "Huo-Yan" laboratories have been launched overseas, which are distributed in more than 30 countries and regions around the world.